Medscape Medical NewsAll articles

Segment 3DPrint

Medviso AB • Radiology • 05/06/2022

510(k)IEC 62304 Class C
FDA Summary PDF

Device Purpose

Segment 3DPrint is a medical software designed for reviewing and segmenting medical images to generate accurate 3D models for diagnostic purposes, visualization, measurement, and treatment planning across orthopaedic, maxillofacial, and cardiovascular applications. It utilizes various image processing techniques, including manual, semi-automatic, and AI-driven segmentation algorithms, to create digital models from medical scans which can also be used to fabricate precise physical replicas via additive manufacturing for enhanced clinical utility.

Summary

Segment 3DPrint is a software application designed for medically trained professionals to review and segment images obtained from medical scanners, as well as existing medical 3D models. Its primary purpose is to generate three-dimensional models for diagnostic use in both paediatric and adult populations. These models are applicable in orthopaedic, maxillofacial, and cardiovascular fields, aiding in visualization, measurement, and treatment planning. Furthermore, the output from Segment 3DPrint can be utilized to fabricate physical replicas of anatomical structures through additive manufacturing methods, enhancing preoperative planning and patient understanding. The software operates on a standard PC platform with a Windows operating system, allowing users to interact via a graphical user interface to import images from various sources, including portable media and network storage. The software employs digital processing to render 3D objects, offering manual, semi-automatic, and AI-driven segmentation capabilities. For instance, its AI bone segmentation algorithm, trained on 20 datasets and validated on 21 distinct datasets, demonstrated high accuracy with a maximum 95th percentile surface distance of less than 1 mm between ground truth and AI-generated segmentation. Performance data from bench and clinical studies indicate that the final 3D models and physical replicas produced using low force stereolithography achieve an accuracy of less than 1 mm, suitable for clinical use across its intended applications. The validation studies involved diverse patient cases, including complex structures, ensuring robustness and reliability for clinical decision support when used in conjunction with expert clinical judgement.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

3D ModelingMedical Image SegmentationAdditive ManufacturingDiagnostic AidTreatment PlanningOrthopaedic ApplicationsMaxillofacial ApplicationsCardiovascular ApplicationsSoftwareAI Bone Segmentation

Device Metadata

Submission Number
K211966
Company
Medviso AB
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. How does the performance of Segment 3DPrint's semi-automatic segmentation algorithms, particularly for soft tissues in cardiovascular or maxillofacial applications, compare to fully manual segmentation in terms of time-efficiency and accuracy?; What specific AI architecture is used for the bone segmentation algorithm, and how was the 'great variety of data' ensured during training and validation to minimize bias and maximize generalizability across different scanner models and patient demographics?; Beyond the stated <1mm accuracy for physical replicas, what is the typical variability or range of accuracy observed across different anatomical regions (e.g., complex cardiovascular structures vs. simpler orthopaedic bones) and additive manufacturing methods?; Are there any known limitations or contraindications for using Segment 3DPrint, for example, with specific image qualities, artifacts, or patient conditions that might compromise model accuracy?; How does Segment 3DPrint integrate with existing clinical workflows, such as Picture Archiving and Communication Systems (PACS) or surgical navigation tools, and what is the typical learning curve for medically trained professionals to achieve proficiency?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score10/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(algorithm, dataset, ground truth, bias)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(network, platform)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Segment 3DPrint - Medviso AB | ESL FDA AI Device Intelligence